Bispecific Antibodies Generate Excitement in Multiple Myeloma TreatmentByMohamad Mohty, MD, PHDJune 15th 2023Mohamad Mohty, MD, PhD, discusses the growing role of bispecific antibodies for the treatment of multiple myeloma.
CAR T Cells Impact the Treatment Landscape Across Hematologic MalignanciesByMohamad Mohty, MD, PHDJanuary 18th 2019Mohamad Mohty, MD, PhD, discusses the promise of CAR T-cell therapy in hematologic malignancies. He says CAR T cells were the superstar of the 2018 ASH Annual Meeting.